MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk-Reference-Cited by-同舟云学术

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

Published:2017-02-03 Issue:1 Volume:17 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Gansmo Liv B.,Bjørnslett Merete,Halle Mari Kyllesø,Salvesen Helga B.,Romundstad Pål,Hveem Kristian,Vatten Lars,Dørum Anne,Lønning Per E.,Knappskog Stian

Funder

Kreftforeningen

Norwegian research council

Norwegian Health Region West

Bergen Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3094-y.pdf

Reference36 articles.

1. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–9.

2. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997;420:25–7.

3. Kubbutat MHG, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature. 1997;387:299–303.

4. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992;69:1237–45.

5. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 1993;362:857–60.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements;Cellular and Molecular Life Sciences;2024-06-20

2. Association of Polymorphic Markers of the TP53, MDM2, and CDKN1A Genes with the Risk of Ovarian Cancer;Russian Journal of Genetics;2022-09

3. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis;Gene;2021-08

4. Association of Murine Double Minute 2 polymorphisms with gastric cancer: A systematic review with meta‑analysis;Biomedical Reports;2021-06-17

5. Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer;Biomarkers;2021-02-28